Menstrual Health awareness in 500 cities of India under way
New Delhi/Mumbai: Though blockbuster film Pad Man has brought the question of menstrual health from fringe towards centre stage, it is not enough. It is still on the backburner making…
Pen is Mightier than Cancer, a survivor scripts an indelible saga of triumph
New Delhi: He pulled off a coup of sorts and inked his battle against cancer on pages of eternity. Medical science may boast of many a cancer survivor but former…
Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain
By Manojna Maddipatla and Tamara Mathias A non-opioid drug developed by Pfizer and Eli Lilly met the main goals of a late-stage study, in which over half of the patients…
Sun Pharma launches psoriasis treatment drug Ilumya in US
Sun Pharmaceutical Industries Tuesday said it has launched its plaque psoriasis treatment drug Ilumya (tildrakizumab-asmn) in the US market.Ilumya in the strength of 100 mg/mL is now available in the…
Johnson and Johnson asked to cut down price of new TB drug
Medicines Sans Frontiers (MSF) has called upon US drug maker c (J&J) to cut down the price of its new tuberculosis drug Bedaquiline, as the high price of the drug…
Free Hepatitis B, C treatment to roll out in Mumbai in December
MUMBAI: Mumbaikars will get free treatment for Hepatitis B and C viral infections when the national programme for control of viral hepatitis takes off in December. Hepatitis B and C…
LifeCell launches ‘Transformational’ Newborn Screening Program
New Delhi, 2018, LifeCell International, India’s stem cell bank and mother and baby diagnostics company today announced the launch of “RightStart” – the world’s first Integrated DNA testing for Newborn…
Noida: Doctors warned as chemists allege some selling medicines to patients
NOIDA: Taking cognisance of complaints from the chemists’ association, the drug licencing authority (DLA) of Meerut division has warned doctors operating out of private clinics/nursing homes in the six districts…
Mumbai: PIL against antibiotics’ sale without prescription
MUMBAI: A lawyer has filed a PIL in the Bombay HC against the Union and state governments, Central Drugs Standard Control Organization (CDSCO) and drug regulator to prevent the rampant…
The government should incentivise setting up infrastructures in tier-2, tier-3 cities: Nivesh Khandelwal
Shahid Akhter, editor, ETHealthworld spoke to Nivesh Khandelwal, Founder and CEO, LetsMD, New Delhi, to know more about challenges by way of affordability in healthcare and how LetsMD is playing…
